InvestorsHub Logo
icon url

slider2

01/25/21 8:21 AM

#77632 RE: PRED2020 #77630

What are we all just guessing or are you the most educated on this subject matter.
Did you feel you just had to share something no matter if there is any logic to it or not?????
icon url

EOT

01/25/21 8:45 AM

#77638 RE: PRED2020 #77630

For Someone who claims to have done a lot of reading and comes up with that number is a complete SMH big time lol. I’ve done a lot of reading and my prediction is a SOLID %95 chance of success. Probably 99 imo. ADVA-27A is always compared to Etoposide. Etoposide is the leading cancer drug in use today that’s approved through FDA, and our drug is 16x more effective and has since improved massively.
“”Google Etoposide and compare””
....do some real DD


Etoposide - IC50.... 59.2
ADVA-27A -IC50.... 1.4.... this is a HUGE difference!!!

WIKIPEDIA.....

—Etoposide (VP-16) is the first agent recognized as a topoisomerase II inhibitor of anticancer drug with IC50 of 59.2 µM. ... The IC50 values of etoposide against the tumor cell lines


—Adva-27a is an excellent inhibitor of Topoisomerase II with an IC50 of only 13.7 micromolar (this number has recently been reduce to 1.44 micromolar as a result of resolving the two isomeric forms of Adva-27a




Adva-27a...clearance is nontoxic in humans .



“Adva-27a has excellent clearance time (half-life = 54 minutes) as indicated by human microsomes stability studies and pharmacokinetics data in rats.
Adva-27a clearance is independent of Cytochrome P450, a mechanism that is less likely to produce toxic intermediates.
Adva-27a is an excellent inhibitor of Topoisomerase II with an IC50 of only 13.7 micromolar (this number has recently been reduce to 1.44 micromolar as a result of resolving the two isomeric forms of Adva-27a).
Adva-27a has shown excellent pharmacokinetics profile as indicated by studies done in rats.
Adva-27a does not inhibit tubulin assembly.”





To do a lot of reading and post a number like %5? .... perfect example of why no one should believe anything without doing their own reliable DD!!!!!!

ADVA-27A....DESTROYS CANCER!!



Adva-27a Anticancer Drug
Adva-27a, a small molecule that has been shown to be exceptionally effective at destroying Multidrug Resistant Cancer Cells,



icon url

elkonig

01/25/21 5:53 PM

#77959 RE: PRED2020 #77630

This company SBFM hasnt spent a dime on R&D for over a year. In fact for 2019 the total spent on R&d was only $15,000.00.
This company has been touting treatments and their patents for years.
END RESULT ZERO, ZILCH NADA AND ZIPPO.